Association of functional COMT Val108/Met polymorphism with smoking cessation in a nicotine replacement therapy

Journal of Neural Transmission

Volumn 119, Issue 12, 2012, Pages 1491-1498

  Sun, Hongqiang ^a,b   Guo, Song ^c,d   Chen, Dafang ^e   Yang, Fude ^a   Zou, Yizhuang ^a   Di, Xiaolan ^a   Cao, Yanjun ^a   Kosten, Thomas ^f   Lu, Lin ^b   Zhang, Xiang Yang ^a,f,g  

^a BEIJING HUILONGGUAN HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d INSTITUTE OF MENTAL HEALTH   (Singapore)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

COMT; Dopamine; Nicotine dependence; Pharmacogenetics; Smoking

Indexed keywords

CARBON MONOXIDE; CATECHOL METHYLTRANSFERASE; COTININE; DRUGS USED IN THE TREATMENT OF ADDICTION; METHIONINE; NICOTINE SUBLINGUAL TABLET; PLACEBO; UNCLASSIFIED DRUG; VALINE;

ADULT; ANXIETY; ARTICLE; CHINESE; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GENOTYPE; HUMAN; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIDE EFFECT; SMOKING CESSATION; SWEATING; TOBACCO DEPENDENCE; TONGUE DISEASE; TONGUE NUMB; TONGUE PAIN; TREATMENT OUTCOME; VOMITING; WEIGHT GAIN; XEROSTOMIA;

ADMINISTRATION, SUBLINGUAL; ADULT; AGED; CATECHOL O-METHYLTRANSFERASE; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PHARMACOGENETICS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; YOUNG ADULT;

EID: 84878360751     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0841-8     Document Type: Article

References (33)

1. Apud JA, Weinberger DR (2007) Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors. CNS Drugs 21(7):535-557
2. Berrettini WH, Lerman CE (2005) Pharmacotherapy and pharmacogenetics of nicotine dependence. Am J Psychiatry 162(8):1441-1451
3. Berrettini WH, Wileyto EP, Epstein L, Restine S, Hawk L, Shields P et al (2007) Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biol Psychiatry 61(1):111-118
4. Beuten J, Payne TJ, Ma JZ, Li MD (2006) Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology 31(3):675-684
5. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S et al (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75(5):807-821
6. Colilla S, Lerman C, Shields PG, Jepson C, Rukstalis M, Berlin J et al (2005) Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet Genomics 15(6):393-398
7. David SP, Johnstone E, Griffiths SE, Murphy M, Yudkin P, Mant D et al (2002) No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. Pharmacogenetics 12(3):265-268
8. Enoch MA, Waheed JF, Harris CR, Albaugh B, Goldman D (2006) Sex differences in the influence of COMT Val158Met on alcoholism and smoking in plains American Indians. Alcohol Clin Exp Res 30(3):399-406
9. Glover ED, Glover PN, Franzon M, Sullivan CR, Cerullo CC, Howell RM et al (2002) A comparison of a nicotine sublingual tablet and placebo for smoking cessation. Nicotine Tob Res 4(4):441-450
10. Guo S, da Chen F, Zhou DF, Sun HQ, Wu GY, Haile CN et al (2007) Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers. Psychopharmacology 190(4):449-456
11. Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A (1999) Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med 159(17):2033-2038
12. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86(9):1119-1127
13. Hughes JR (2003) Motivating and helping smokers to stop smoking. J Gen Intern Med 18(12):1053-1057
14. Johnstone EC, Elliot KM, David SP, Murphy MF, Walton RT, Munafo MR (2007) Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev 16(6):1065-1069
15. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6(3):243-250
16. Lam TH, Abdullah AS, Chan SS, Hedley AJ (2005) Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation. Psychopharmacology 177(4):400-408
17. Lee DW, Chan AC, Sze TS, Ko CW, Poon CM, Chan KC et al (2002) Patient-controlled sedation versus intravenous sedation for colonoscopy in elderly patients: a prospective randomized controlled trial. Gastrointest Endosc 56(5):629-632
18. Lerman C, Niaura R (2002) Applying genetic approaches to the treatment of nicotine dependence. Oncogene 21(48):7412-7420
19. Mannisto PT, Kaakkola S (1999) Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51(4):593-628
20. Mannisto PT, Ulmanen I, Lundstrom K, Taskinen J, Tenhunen J, Tilgmann C et al (1992) Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors. Prog Drug Res 39:291-350
21. Munafo MR, Lerman C, Niaura R, Shields AE, Swan GE (2005) Smoking cessation treatment: pharmacogenetic assessment. Curr Opin Mol Ther 7(3):202-208
22. Munafo MR, Johnstone EC, Guo B, Murphy MF, Aveyard P (2008) Association of COMT Val108/158Met genotype with smoking cessation. Pharmacogenet Genomics 18(2):121-128
23. Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382(6588):255-257
24. Rice ME, Cragg SJ (2004) Nicotine amplifies reward-related dopamine signals in striatum. Nat Neurosci 7(6):583-584
25. Schmack K, Schlagenhauf F, Sterzer P, Wrase J, Beck A, Dembler T et al (2008) Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation. Neuroimage 42(4):1631-1638
26. Shield AJ, Thomae BA, Eckloff BW, Wieben ED, Weinshilboum RM (2004) Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol Psychiatry 9(2):151-160
27. Sun HQ, Guo S, Chen DF, Jiang ZN, Liu Y, Di XL, Yang FD, Zhang XY, Kosten TR, Lu L (2009) Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers. Am J Drug Alcohol Abuse 35(3):183-188
28. Tochigi M, Suzuki K, Kato C, Otowa T, Hibino H, Umekage T et al (2007) Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior. Pharmacogenet Genomics 17(10):867-872
29. Tunbridge EM, Huber A, Farrell SM, Stumpenhorst K, Harrison PJ, Walton ME (2012). The Role of Catechol-O-Methyltransferase in Reward Processing and Addiction. CNS Neurol Disord Drug Targets [Epub ahead of print]
30. Wallstrom M, Nilsson F, Hirsch JM (2000) A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction 95(8):1161-1171
31. Yang GH, Ma JM, Liu N, Zhou LN (2005) Smoking and passive smoking in Chinese, 2002. Zhonghua Liu Xing Bing Xue Za Zhi 26(2):77-83
32. Yang G, Kong L, Zhao W, Wan X, Zhai Y, Chen LC et al (2008) Emergence of chronic non-communicable diseases in China. Lancet 372(9650):1697-1705
33. Zhang G, Spencer PH, Jin LQ, Cohlberg JA, Beaulieu JM, Julien JP et al (2004) The single neurofilament subunit of lamprey may need another element for filament assembly. J Comp Neurol 471(2):188-200